
Thioridazine inhibits self-renewal in breast cancer cells via DRD2-dependent STAT3 inhibition, but induces a G1 arrest independent of DRD2
Author(s) -
M. Tegowski,
Claire Fan,
A.S. Baldwin
Publication year - 2018
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/y358-dw97
Subject(s) - thioridazine , breast cancer , cancer research , medicine , chemistry , oncology , pharmacology , cancer , chlorpromazine